Skip to content
DataLookout
Menu

RESTNCT07068243

REctus Sheath Trial

StatusRecruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Eligibility criteria expanded, about 15 words
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2026 to Oct 26, 2026
  2. Notable Start date: May 2026 to Sep 2026
    • Primary completion pushed from Sep 2026 to Feb 2027
    • Study completion pushed from Dec 2026 to Apr 2027
    v3
  3. Notable Primary completion date: Nov 2025 to Sep 2026
    • Start date: Nov 2025 to May 2026
    • Study completion date: Jan 2026 to Dec 2026
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Temperature discrimination
Timeframe: 60 to 90 minutes post-block
Mechanical discrimination
Timeframe: 60 to 90 minutes post-block
Cutaneous distribution mapping
Timeframe: 60 to 90 minutes post-block

Secondary (2)

Direct visualization of the local anesthetic spread
Measurement of the local anesthetic spread in each dermatome with the US

Arms and interventions

Transverse Approach to the Rectus Sheath BlockActive comparator

In the transverse approach, the US probe will be positioned perpendicular to the he rectus abdominis muscle's fibers, and the needle will be inserted in-plane from lateral to medial.

Longitudinal Approach to the Rectus Sheath BlockExperimental

In contrast, the longitudinal approach will involve aligning the probe parallel to the rectus muscle fibers, with the needle advanced in-plane from cephalad to caudad.

Drugs: 1.0% lidocaine with epinephrine (1:100,000)

Sites

1 site in 1 country

  • Duke University Medical CenterDurham, North Carolina, United States